The ultimate guidebook on everything you need to know about reducing hospital readmissions—the most common risk factors, the reimbursement issues, and how real-world hospitals are solving the problem.
A new study, funded by NIH, provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of COPD.
The biggest drug categories and medications set for approval this year.
COPD is a costly disease for patients and payers alike—but in order to control costs, you must first know what’s behind them.
COPD is a chronic, progressive disorder that can lead to early death. Here are some ways to help mitigate the risk of developing this debilitating disorder.
In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?
Home non-invasive ventilation supports longer lives, fewer readmissions, and lower costs than other devices, based on findings of a KPMG study.
The launch of a new connected health platform will aid in management of diseases such as diabetes.
COPD strikes 6.4% of Americans. While smoking is a big contributor, these seven other risk factors deserve more attention.
Healthcare organizations should focus on these things to improve health management of COPD patients and reduce costs.